Valuation Alfresa Holdings Corporation
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
|
Market Closed -
Japan Exchange
09:30:00 23/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,406.50 JPY | +1.45% |
|
+3.26% | -1.01% |
| 10-05 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| 07-01 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
Company Valuation: Alfresa Holdings Corporation
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 343,826 | 343,217 | 415,318 | 383,847 | 459,384 | 422,133 | - | - |
| Change | - | -0.18% | 21.01% | -7.58% | 19.68% | -8.11% | - | - |
| Enterprise Value (EV) | 168,429 | 186,950 | 236,499 | 242,307 | 301,938 | 422,133 | 422,133 | 422,133 |
| Change | - | 11% | 26.5% | 2.46% | 24.61% | 39.81% | 0% | 0% |
| P/E | 11.1x | 13.3x | 14.4x | 14.3x | 11x | 18.2x | 15.3x | 16x |
| PBR | 0.73x | 0.7x | 0.87x | 0.8x | 0.91x | 0.84x | 0.81x | 0.81x |
| PEG | - | -0.8x | 0.7x | -3.34x | 0.2x | -0.4x | 0.8x | -3.93x |
| Capitalization / Revenue | 0.13x | 0.13x | 0.15x | 0.13x | 0.15x | 0.13x | 0.13x | 0.13x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 0.13x | 0.13x | 0.13x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 8.18x | 8.08x | 8.04x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 12.3x | 11.4x | 11.1x |
| EV / FCF | 0x | -0x | 0x | -0x | 0x | 20.1x | 25.8x | 35.2x |
| FCF Yield | 11.3% | -2.17% | 17.4% | -4.12% | 6.5% | 4.97% | 3.88% | 2.84% |
| Dividend per Share 2 | 54 | 57 | 70 | 63 | 68 | 71 | 79.67 | 85 |
| Rate of return | 3.18% | 3.36% | 3.15% | 2.98% | 2.69% | 2.95% | 3.31% | 3.53% |
| EPS 2 | 153.6 | 127.4 | 154.1 | 147.5 | 229.6 | 132.4 | 157 | 150.6 |
| Distribution rate | 35.2% | 44.7% | 45.4% | 42.7% | 29.6% | 53.6% | 50.8% | 56.5% |
| Net sales 1 | 2,585,643 | 2,696,069 | 2,858,500 | 2,961,051 | 3,104,064 | 3,193,819 | 3,288,778 | 3,340,075 |
| EBITDA 1 | 41,915 | 43,450 | 51,974 | 58,607 | 51,212 | 51,628 | 52,221 | 52,514 |
| EBIT 1 | 29,091 | 30,148 | 38,460 | 38,080 | 36,164 | 34,398 | 36,942 | 38,069 |
| Net income 1 | 32,182 | 25,786 | 29,558 | 27,389 | 41,746 | 23,414 | 27,149 | 26,886 |
| Net Debt | -175,397 | -156,267 | -178,819 | -141,540 | -157,446 | - | - | - |
| Reference price 2 | 1,699.00 | 1,696.00 | 2,222.50 | 2,111.50 | 2,528.00 | 2,406.50 | 2,406.50 | 2,406.50 |
| Nbr of stocks (in thousands) | 202,370 | 202,369 | 186,870 | 181,789 | 181,719 | 175,413 | - | - |
| Announcement Date | 5/16/22 A | 5/15/23 A | 5/14/24 A | 5/15/25 A | 5/15/26 A | - | - | - |
1JPY in Million2JPY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 18.18x | - | - | 2.95% | 2.69B | ||
| 34.01x | 4.08x | 15.69x | 2.48% | 179B | ||
| 23.84x | 4.68x | 16.31x | 1.17% | 118B | ||
| 20.4x | 3.54x | 12.67x | 2.97% | 117B | ||
| 31.64x | 3.06x | 12.36x | 2.24% | 93.26B | ||
| 18.15x | 0.21x | 13.14x | 0.72% | 63.16B | ||
| 31.42x | 7.87x | 20.23x | 1.26% | 55.68B | ||
| 39.45x | 3.63x | 12.37x | 2.1% | 54.18B | ||
| 37.95x | 9.42x | 26.36x | -.--% | 44.15B | ||
| 40.74x | 3.29x | 12.28x | 0.53% | 33.95B | ||
| Average | 29.58x | 4.42x | 15.71x | 1.64% | 76.11B | |
| Weighted average by Cap. | 29.41x | 4.16x | 15.26x | 1.83% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 2784 Stock
- Valuation Alfresa Holdings Corporation
Select your edition
All financial news and data tailored to specific country editions
















